Patents by Inventor Jawad Sarwar

Jawad Sarwar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunogenic composition comprising Panton-Valentine Leukocidin (PVL) derived polypeptides
    Patent number: 10023848
    Abstract: The present disclosure provides immunogenic compositions useful in prevention and treatment of Staphylococcus aureus infection. In particular, the disclosure provides methods of inducing an immune response against a panton-valentine leukocidin (PVL)-expressing S. aureus, methods of preventing or treating S. aureus infections, and composition for preventing or treating S. aureus infections.
    Type: Grant
    Filed: November 30, 2012
    Date of Patent: July 17, 2018
    Assignee: INTEGRATED BIOTHERAPEUTICS, INC
    Inventors: Mohammad Javad Aman, Rajan Prasad Adhikari, Hatice Karauzum, Jawad Sarwar, Sergey Shulenin, Sathya Venkataramani, Kelly Lyn Warfield, Tam Luong Nguyen
  • Immunogenic Composition Comprising Panton-Valentine Leukocidin (PVL) Derived Polypeptides
    Publication number: 20140308291
    Abstract: The present disclosure provides immunogenic compositions useful in prevention and treatment of Staphylococcus aureus infection. In particular, the disclosure provides methods of inducing an immune response against a panton-valentine leukocidin (PVL)-expressing S. aureus, methods of preventing or treating S. aureus infections, and composition for preventing or treating S. aureus infections.
    Type: Application
    Filed: November 30, 2012
    Publication date: October 16, 2014
    Inventors: Mohammad Javad Aman, Rajan Prasad Adhikari, Hatice Karauzum, Jawad Sarwar, Sergey Shulenin, Sathya Venkataramani, Kelly Lyn Warfield, Tam Luong Nguyen
  • Method of protecting against staphylococcal infection
    Patent number: 7754225
    Abstract: A method of preventing or treating staphylococcal bacterial infection in an individual is disclosed. A vaccine based on a conjugate of PS1 polysaccharide antigen can be used for active protection in individuals who are to be subjected to conditions that place them at immediate risk of developing a bacterial infection, as would be case in the context of a catheterization or a surgical procedure. Alternatively, antibodies raised in response to the antigen can be used to treat or to provide passive protection to individuals. The method can be used in a population of patients at risk for infection by various species of Staphylococcus or various types of Staphylococcus epidermidis.
    Type: Grant
    Filed: July 20, 2006
    Date of Patent: July 13, 2010
    Assignee: Glaxosmithkline Biologicals S.A.
    Inventors: Ali Fattom, Jawad Sarwar, Zuzana Kossaczka, Kimberly L. Taylor, Sofiane Ennifar
  • Method of protecting against staphylococcal infection
    Publication number: 20080019983
    Abstract: A method of preventing or treating staphylococcal bacterial infection in an individual is disclosed. A vaccine based on a conjugate of PS1 polysaccharide antigen can be used for active protection in individuals who are to be subjected to conditions that place them at immediate risk of developing a bacterial infection, as would be case in the context of a catheterization or a surgical procedure. Alternatively, antibodies raised in response to the antigen can be used to treat or to provide passive protection to individuals. The method can be used in a population of patients at risk for infection by various species of Staphylococcus or various types of Staphylococcus epidermidis.
    Type: Application
    Filed: July 20, 2006
    Publication date: January 24, 2008
    Applicant: Nabi Biopharmaceuticals
    Inventors: Ali Fattom, Jawad Sarwar, Zuzana Kossaczka, Kimberly L. Taylor, Sofiane Ennifar
  • Method of protecting against staphylococcal infection
    Publication number: 20060228368
    Abstract: A method of preventing or treating staphylococcal bacterial infection in an individual is disclosed. A vaccine based on a conjugate the 336 polysaccharide antigen can be used for active protection in individuals who are to be subjected to conditions that place them at immediate risk of developing a bacterial infection, as would be case in the context of a catheterization or a surgical procedure. Alternatively, antibodies raised in response to the antigen can be used to treat or to provide passive protection to individuals. The method can be used in a population of patients at risk for infection by various species of Staphylococcus or various types of Staphylococcus aureus.
    Type: Application
    Filed: April 7, 2005
    Publication date: October 12, 2006
    Applicant: Nabi Biopharmaceuticals
    Inventors: Ali Fattom, Jawad Sarwar, Zuzana Kossaczka, Kimberly Taylor, Sofiane Ennifar